SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-183327
Filing Date
2022-06-28
Accepted
2022-06-28 07:40:56
Documents
19
Period of Report
2022-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d362847d8k.htm   iXBRL 8-K 34284
2 EX-1.1 d362847dex11.htm EX-1.1 243092
3 EX-4.1 d362847dex41.htm EX-4.1 68982
4 EX-5.1 d362847dex51.htm EX-5.1 37380
5 EX-8.1 d362847dex81.htm EX-8.1 7750
9 GRAPHIC g362847dsp73.jpg GRAPHIC 16743
10 GRAPHIC g362847dsp73a.jpg GRAPHIC 12372
11 GRAPHIC g362847g0628012231881.jpg GRAPHIC 2201
  Complete submission text file 0001193125-22-183327.txt   651505

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20220624.xsd EX-101.SCH 2866
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20220624_lab.xml EX-101.LAB 17927
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20220624_pre.xml EX-101.PRE 11244
13 EXTRACTED XBRL INSTANCE DOCUMENT d362847d8k_htm.xml XML 3445
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 221046500
SIC: 2835 In Vitro & In Vivo Diagnostic Substances